Antimicrobial Resistance and Alternatives to Antimicrobials roadmap:
Diagnostic Tests
Roadmap for Immunomodulators
Download Alternatives-to-Antibiotics-Report-2022
---
config:
theme: default
defaultRenderer: 'elk'
themeVariables:
lineColor: "red"
---
flowchart LR
22829["
2
Chemicals / phytochemicals1
Immunomodulatory agents3
Other immunomodulators1
Immunomodulatory agents4
PRR Agonists1
Immunomodulatory agents5
Microorganisms and their products as immunotherapy1
Immunomodulatory agents6
Microbiota optimisation1
Immunomodulatory agents7
Immune pathway regulation2
Chemicals / phytochemicals7
Immune pathway regulation3
Other immunomodulators7
Immune pathway regulation4
PRR Agonists7
Immune pathway regulation5
Microorganisms and their products as immunotherapy7
Immune pathway regulation6
Microbiota optimisation7
Immune pathway regulation8
Infection/vaccination8
Infection/vaccination9
Acquired immunity10
Early life programming of immune systems7
Immune pathway regulation11
Nutritional status & immune protection7
Immune pathway regulation11
Nutritional status & immune protection12
Metabolic cost12
Metabolic cost7
Immune pathway regulation13
Immune-inflammatory balance10
Early life programming of immune systems13
Immune-inflammatory balance11
Nutritional status & immune protection13
Immune-inflammatory balance12
Metabolic cost13
Immune-inflammatory balance7
Immune pathway regulation13
Immune-inflammatory balance14
Epithellai cell function/matabolism at mucasal surfaces13
Immune-inflammatory balance15
Host-microorganism interaction14
Epithellai cell function/matabolism at mucasal surfaces13
Immune-inflammatory balance14
Epithellai cell function/matabolism at mucasal surfaces10
Early life programming of immune systems14
Epithellai cell function/matabolism at mucasal surfaces11
Nutritional status & immune protection14
Epithellai cell function/matabolism at mucasal surfaces12
Metabolic cost14
Epithellai cell function/matabolism at mucasal surfaces7
Immune pathway regulation15
Host-microorganism interaction13
Immune-inflammatory balance15
Host-microorganism interaction7
Immune pathway regulation15
Host-microorganism interaction10
Early life programming of immune systems15
Host-microorganism interaction11
Nutritional status & immune protection15
Host-microorganism interaction12
Metabolic cost16
Innate defense pathways and sensory mechanisms14
Epithellai cell function/matabolism at mucasal surfaces16
Innate defense pathways and sensory mechanisms15
Host-microorganism interaction17
Understanding of immune competence16
Innate defense pathways and sensory mechanismsLead Summary | Challenges and gap analysis | |
---|---|---|
1 | Immunomodulatory agents | Immunomodulatory agents |
2 | Chemicals / phytochemicals | Chemicals / phytochemicals |
3 | Other immunomodulators | Other immunomodulators (e.g. AMPs, nanozybiotic…) |
4 | PRR Agonists | Pattern Recognition Receptors (PRRs) agonists |
5 | Microorganisms and their products as immunotherapy | Microorganisms and their products as immunotherapy |
6 | Microbiota optimisation | Microbiota optimisation (including microbiome) |
7 | Immune pathway regulation | Immune pathway regulation |
8 | Infection/vaccination | Infection/vaccination |
9 | Acquired immunity | Acquired immunity – see Vaccinology Roadmap |
10 | Early life programming of immune systems | Early life programming of immune system |
11 | Nutritional status & immune protection | Nutrients & immune protection |
12 | Metabolic cost | Metabolic cost |
13 | Immune-inflammatory balance | Immune-inflammatory balance |
14 | Epithellai cell function/matabolism at mucasal surfaces | Epithellai cell function/matabolism at mucasal surfaces |
15 | Host-microorganism interaction | Host-microorganism interaction |
16 | Innate defense pathways and sensory mechanisms | Innate defence pathways |
17 | Understanding of immune competence |